Production (Stage)
ACADIA Pharmaceuticals Inc.
ACAD
$21.98
$0.432.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 681.58M | 755.99M | 565.33M | 500.94M | 470.52M |
| Total Receivables | 113.71M | 104.70M | 110.36M | 110.39M | 100.08M |
| Inventory | 22.95M | 21.95M | 61.04M | 71.53M | 61.94M |
| Prepaid Expenses | 52.70M | 55.68M | 51.55M | 46.06M | 42.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 870.94M | 938.32M | 788.28M | 728.92M | 675.30M |
|
|
|||||
| Total Current Assets | 870.94M | 938.32M | 788.28M | 728.92M | 675.30M |
| Net Property, Plant & Equipment | 54.11M | 50.79M | 48.24M | 56.53M | 58.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 117.06M | 119.78M | 105.52M | 107.86M | 110.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.25M | 78.87M | 34.83M | 20.79M | 10.95M |
| Total Assets | 1.13B | 1.19B | 976.87M | 914.10M | 855.10M |
|
|
|||||
| Total Accounts Payable | 18.10M | 16.19M | 19.08M | 19.88M | 19.33M |
| Total Accrued Expenses | 264.02M | 254.44M | 236.33M | 227.92M | 221.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.37M | 9.96M | 8.95M | 10.47M | 10.45M |
| Total Finance Division Other Current Liabilities | 9.05M | 114.28M | 79.58M | 79.58M | 79.58M |
| Total Other Current Liabilities | 9.05M | 114.28M | 79.58M | 79.58M | 79.58M |
| Total Current Liabilities | 302.53M | 394.87M | 343.95M | 337.85M | 330.60M |
|
|
|||||
| Total Current Liabilities | 302.53M | 394.87M | 343.95M | 337.85M | 330.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.63M | 42.04M | 40.42M | 47.19M | 49.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.96M | 18.06M | 15.32M | 12.36M | 11.27M |
| Total Liabilities | 367.13M | 454.96M | 399.69M | 397.40M | 391.06M |
|
|
|||||
| Common Stock & APIC | 2.95B | 2.94B | 2.92B | 2.90B | 2.88B |
| Retained Earnings | -2.19B | -2.20B | -2.35B | -2.38B | -2.41B |
| Treasury Stock & Other | 437.00K | 292.00K | 858.00K | -339.00K | -229.00K |
| Total Common Equity | 765.24M | 732.79M | 577.18M | 516.70M | 464.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 765.24M | 732.79M | 577.18M | 516.70M | 464.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 765.24M | 732.79M | 577.18M | 516.70M | 464.04M |
|
|
|||||